Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 2
2015 3
2016 2
2017 1
2018 3
2019 3
2020 2
2021 2
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
[Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia].
Mizutani Y, Kusakabe S, Fukushima K, Murakami H, Hamada M, Hasegawa C, Mizuta E, Yamaguchi Y, Nakai R, Kurashige R, Hino A, Ueda T, Fujita J, Miyamura T, Hosen N. Mizutani Y, et al. Among authors: ueda t. Rinsho Ketsueki. 2024;65(2):78-83. doi: 10.11406/rinketsu.65.78. Rinsho Ketsueki. 2024. PMID: 38448002 Japanese.
First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
Jo T, Ueda T, Akahoshi Y, Kondo T, Uchida N, Tanaka M, Nakamae H, Doki N, Ota S, Sawa M, Ohigashi H, Maruyama Y, Takayama N, Nishida T, Hiramoto N, Katayama Y, Kanda Y, Ichinohe T, Atsuta Y, Arai Y; Japanese Society for Transplantation and Cellular Therapy (JSTCT). Jo T, et al. Among authors: ueda t. Br J Haematol. 2024 Feb 29. doi: 10.1111/bjh.19372. Online ahead of print. Br J Haematol. 2024. PMID: 38420726
Successful Bridging to Allogeneic Hematopoietic Stem Cell Transplantation by Azacitidine and Venetoclax in a Case of Acute Myeloid Leukemia With t(3;3)(q21.3;q26.2) Developed Early After Orthotopic Heart Transplantation.
Ueda T, Fujita J, Akazawa Y, Kawamura A, Matsui T, Hino A, Kusakabe S, Sudo T, Fukushima K, Yokota T, Miyagawa S, Sakata Y, Hosen N. Ueda T, et al. Transplant Proc. 2023 Apr;55(3):711-714. doi: 10.1016/j.transproceed.2023.02.026. Epub 2023 Apr 2. Transplant Proc. 2023. PMID: 37012142
[Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination].
Senda A, Saito H, Kusakabe S, Yoshida K, Shibata K, Kida S, Toda J, Hino A, Ueda T, Fujita J, Fukushima K, Yokota T, Kashiwagi H, Hosen N. Senda A, et al. Among authors: ueda t. Rinsho Ketsueki. 2023;64(1):35-41. doi: 10.11406/rinketsu.64.35. Rinsho Ketsueki. 2023. PMID: 36775305 Japanese.
Clinical implications of combination therapy with quizartinib and craniospinal irradiation for refractory acute myeloid leukemia positive for FMS-like tyrosine kinase 3-internal tandem duplication with central nervous system involvement.
Suga M, Fukushima K, Ueda T, Arai Y, Nakagawa S, Minami Y, Toda J, Hino A, Fujita J, Yokota T, Hosen N. Suga M, et al. Among authors: ueda t. Clin Case Rep. 2022 Feb 4;10(2):e05384. doi: 10.1002/ccr3.5384. eCollection 2022 Feb. Clin Case Rep. 2022. PMID: 35140970 Free PMC article.
24 results